April 21, 2024 5:15 pm
Search
Close this search box.

Opill, the first over-the-counter birth control pill, will be on shelves soon − here are some key things to know

The Food and Drug Administration’s 2023 approval of the first over-the-counter birth control pill, called Opill, broadened the options for people seeking to prevent pregnancy. On March 4, 2024, the pill’s manufacturer, Perrigo Company, announced that it has started shipping Opill and that consumers can expect to see it on shelves by the end of the month.

When It Comes to Ketamine, Meta’s Posting Policy Is No Party to Decipher

Whether on Facebook or Instagram, patients and clinics alike are giddy about the possibilities of ketamine. But it is a drug that can be abused and can be deadly. Thus, ketamine is the latest challenge for Meta, the social media platforms’ parent company, which for years has struggled to moderate posts and ads touting health-related products like weight loss supplements and dodgy covid-19 cures.

Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers

President Joe Biden’s battle against high drug prices is mostly embodied in the IRA, as the law is known — a grab bag of measures intended to give Medicare patients immediate relief and, in the long term, to impose government controls on what pharmaceutical companies charge for their products. The law represents the most significant overhaul for the U.S. drug marketplace in decades.